Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by toinv261on Jul 07, 2014 10:34am
229 Views
Post# 22720921

Question re loan vote

Question re loan voteThe question I'm asking is quite naive so bare with me please.

Prior to the special meeting on August 13 an information circular will be sent out by RVX. It probably will define who the eligible voters will be in terms such as "shareholders on such and such a date will be eligible to vote on the resolution". This will probably be a date established prior the circular is sent out.

In very rough numbers the vote will be based on the following:
  • outstanding shares - 85mm
  • Eastern shares - 15mm
  • voting shares - 70mm
  • NGN - 8mm
  • Don - 3mm
  • Dir and officers - 1mm - based on the June financing only...i.e. not what they already owned
  • These 3 groups = 12mm or 17% of the voting shares.
  • This leaves 58mm shares.
  • Other insiders and related insiders - ??????? I have no idea so big guess - 8mm. So these groups could account for 29% of the voters (recognizing I made up the insider guess.
  • 71% are open to vote the way they want.

I have no idea at all of how this 71% or whatever the real number is held. I'm guessing these shares are widely held by investors that want to see RVX move forward.

I have just assumed that everyone will vote in favour of this financing plan.

Can anyone think of why or who would vote against it? Would anyone or group attempt to purchase large blocks of shares prior to the vote cut off date?

Cheers
Toinv

P.S. By the way I'm not a conspiracy theorist although my posting looks pretty foolish. Apologies!
Bullboard Posts